Tapewire

Nasdaq · USD

IPSC

Century Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5739
SEC CIK
0001850119
Parsed reports
187

Last 12 months

Inside the activity.

3 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202513
Dec 202522
Jan 202600
Feb 202601
Mar 202604
Apr 202600
May 202601
Jun 202604
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 19, 2025 Filed Nov 20, 2025 23:02 UTC
Pfeiffenberger BrentDirector · President and CEO
PurchaseCommon Stock 35,000 $0.50 $17,328.50
Disclosure

SEC source: 0002001162-25-000005 · form4-11202025_111138.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,271,453

F1 · kind: All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.488 to $0.5005. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:19 UTC
Pfeiffenberger BrentDirector · President and CEO
SaleCommon Stock 32,456 $0.45 $14,735.02
Disclosure

SEC source: 0002001162-25-000003 · form4-11192025_091118.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,236,453

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
November 03, 2025 Filed Nov 5, 2025 21:01 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 292 $0.59 $171.11
Disclosure

SEC source: 0001867173-25-000003 · form4-11052025_091147.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,131

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
September 18, 2025 Filed Sep 22, 2025 20:56 UTC
Cowan ChadChief Scientific Officer
GrantCommon Stock 762,543 $0.00 $0.00
Disclosure

SEC source: 0002039294-25-000004 · form4-09222025_080929.xml · nonDerivative · entry 1

Cowan Chad · CIK 0002039294 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 992,489

F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on October 1, 2026, with the remaining 50% vesting on October 1, 2027, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 21:34 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 263 $0.50 $131.50
Disclosure

SEC source: 0001062993-25-015526 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,423

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 21:29 UTC
Pfeiffenberger BrentDirector · President and CEO
SaleCommon Stock 488 $0.50 $244.00
Disclosure

SEC source: 0001062993-25-015525 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,268,909

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 21:28 UTC
Russotti GregorySee Remarks
SaleCommon Stock 539 $0.50 $269.50
Disclosure

SEC source: 0001062993-25-015524 · form4.xml · nonDerivative · entry 1

Russotti Gregory · CIK 0001867305 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 391,508

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
August 14, 2025 Filed Aug 18, 2025 20:14 UTC
Pfeiffenberger BrentDirector · President and CEO
GrantCommon Stock 1,587,614 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-014562 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,269,397

F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on August 14, 2027, with the remaining 50% vesting on August 14, 2028, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:13 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 296 $0.53 $158.06
Disclosure

SEC source: 0001062993-25-013720 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,686

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:26 UTC GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011788 · form4.xml · derivative · entry 1

Blackwell Kimberly · CIK 0001816465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:26 UTC GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011787 · form4.xml · derivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:25 UTC GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011786 · form4.xml · derivative · entry 1

Riva Alessandro · CIK 0001867172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:25 UTC GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011785 · form4.xml · derivative · entry 1

Carlo Rizzuto · CIK 0001817033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:24 UTC
Quimi DaphneDirector
GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011784 · form4.xml · derivative · entry 1

Quimi Daphne · CIK 0001543031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:23 UTC GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011783 · form4.xml · derivative · entry 1

BUTITTA CYNTHIA M · CIK 0001222082 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 22:23 UTC GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-011782 · form4.xml · derivative · entry 1

Walbert Timothy P · CIK 0001349376 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:05 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 4,904 $0.62 $3,050.29
Disclosure

SEC source: 0001062993-25-011429 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,982

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:05 UTC
Farid AdrienneChief Operations Officer
SaleCommon Stock 552 $0.62 $343.34
Disclosure

SEC source: 0001062993-25-011428 · form4.xml · nonDerivative · entry 1

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,141

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:05 UTC
Pfeiffenberger BrentDirector · President and CEO
SaleCommon Stock 475 $0.62 $295.45
Disclosure

SEC source: 0001062993-25-011427 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,681,783

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:04 UTC
Russotti GregorySee Remarks
SaleCommon Stock 526 $0.62 $327.17
Disclosure

SEC source: 0001062993-25-011426 · form4.xml · nonDerivative · entry 1

Russotti Gregory · CIK 0001867305 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,047

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:19 UTC
Pfeiffenberger BrentDirector · President and CEO
SaleCommon Stock 29,552 $0.55 $16,135.39
Disclosure

SEC source: 0001062993-25-009868 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,682,258

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
May 05, 2025 Filed May 7, 2025 20:38 UTC
Farid AdrienneChief Operations Officer
SaleCommon Stock 1,024 $0.55 $563.20
Disclosure

SEC source: 0001062993-25-008775 · form4.xml · nonDerivative · entry 1

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,693

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
May 05, 2025 Filed May 7, 2025 20:38 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 295 $0.55 $162.25
Disclosure

SEC source: 0001062993-25-008772 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,886

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:31 UTC
Cowan ChadChief Scientific Officer
GrantStock Option (right to buy) · Derivative 19,500 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-005293 · form4.xml · derivative · entry 3

Cowan Chad · CIK 0002039294 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,500

Underlying: Common Stock · 19,500 shares

Expires 2035-03-11

F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:31 UTC
Cowan ChadChief Scientific Officer
GrantCommon Stock 19,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005293 · form4.xml · nonDerivative · entry 1

Cowan Chad · CIK 0002039294 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,306

F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:31 UTC
Conn MorganChief Finanical Officer
GrantStock Option (right to buy) · Derivative 19,500 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-005294 · form4.xml · derivative · entry 2

Conn Morgan · CIK 0001974124 · Chief Finanical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,500

Underlying: Common Stock · 19,500 shares

Expires 2035-03-11

F2 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:31 UTC
Conn MorganChief Finanical Officer
GrantCommon Stock 19,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005294 · form4.xml · nonDerivative · entry 1

Conn Morgan · CIK 0001974124 · Chief Finanical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,648

F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:28 UTC
Russotti GregorySee Remarks
GrantStock Option (right to buy) · Derivative 120,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-005291 · form4.xml · derivative · entry 4

Russotti Gregory · CIK 0001867305 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2035-03-11

F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:28 UTC
Russotti GregorySee Remarks
GrantCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005291 · form4.xml · nonDerivative · entry 2

Russotti Gregory · CIK 0001867305 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,573

F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:30 UTC
Pfeiffenberger BrentDirector · President and CEO
GrantStock Option (right to buy) · Derivative 521,500 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-005292 · form4.xml · derivative · entry 3

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 521,500

Underlying: Common Stock · 521,500 shares

Expires 2035-03-11

F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:30 UTC
Pfeiffenberger BrentDirector · President and CEO
GrantCommon Stock 521,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005292 · form4.xml · nonDerivative · entry 2

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,711,810

F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:27 UTC
Farid AdrienneChief Operations Officer
GrantStock Option (right to buy) · Derivative 120,000 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-005289 · form4.xml · derivative · entry 3

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2035-03-11

F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:27 UTC
Farid AdrienneChief Operations Officer
GrantCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005289 · form4.xml · nonDerivative · entry 2

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,717

F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:26 UTC
Carr DouglasSVP Finance & Operations
GrantStock Option (right to buy) · Derivative 95,625 $0.00 Strike: $0.60 $0.00
Disclosure

SEC source: 0001062993-25-005288 · form4.xml · derivative · entry 3

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,625

Underlying: Common Stock · 95,625 shares

Expires 2035-03-11

F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 23:26 UTC
Carr DouglasSVP Finance & Operations
GrantCommon Stock 95,625 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005288 · form4.xml · nonDerivative · entry 2

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 411,181

F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 23:28 UTC
Russotti GregorySee Remarks
SaleCommon Stock 2,360 $0.62 $1,451.40
Disclosure

SEC source: 0001062993-25-005291 · form4.xml · nonDerivative · entry 1

Russotti Gregory · CIK 0001867305 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,573

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 23:30 UTC
Pfeiffenberger BrentDirector · President and CEO
SaleCommon Stock 2,235 $0.62 $1,374.53
Disclosure

SEC source: 0001062993-25-005292 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,190,310

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 23:27 UTC
Farid AdrienneChief Operations Officer
SaleCommon Stock 2,359 $0.62 $1,450.79
Disclosure

SEC source: 0001062993-25-005289 · form4.xml · nonDerivative · entry 1

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,717

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 23:26 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 1,240 $0.62 $762.60
Disclosure

SEC source: 0001062993-25-005288 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,556

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:00 UTC
Pfeiffenberger BrentDirector · President and CEO
SaleCommon Stock 34,712 $0.78 $27,179.50
Disclosure

SEC source: 0001062993-25-003043 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,192,545

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 22:30 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 351 $0.78 $273.78
Disclosure

SEC source: 0001062993-25-001755 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,796

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 22:31 UTC
Farid AdrienneChief Operations Officer
SaleCommon Stock 1,054 $0.78 $822.12
Disclosure

SEC source: 0001062993-25-001756 · form4.xml · nonDerivative · entry 1

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,076

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:57 UTC
Pfeiffenberger BrentDirector · President and CEO
Tax withholdingCommon Stock 243,447 $1.44 $350,563.68
Disclosure

SEC source: 0001062993-24-020202 · form4.xml · nonDerivative · entry 1

Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,227,257

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
November 04, 2024 Filed Nov 5, 2024 21:59 UTC
Farid AdrienneChief Operations Officer
SaleCommon Stock 1,033 $1.23 $1,267.49
Disclosure

SEC source: 0001062993-24-018339 · form4.xml · nonDerivative · entry 1

Farid Adrienne · CIK 0001867310 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,130

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
November 04, 2024 Filed Nov 5, 2024 21:59 UTC
Carr DouglasSVP Finance & Operations
SaleCommon Stock 283 $1.23 $347.24
Disclosure

SEC source: 0001062993-24-018338 · form4.xml · nonDerivative · entry 2

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,147

F2 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:59 UTC
Carr DouglasSVP Finance & Operations
Tax withholdingCommon Stock 16,611 $1.26 $20,929.86
Disclosure

SEC source: 0001062993-24-018338 · form4.xml · nonDerivative · entry 1

Carr Douglas · CIK 0001867173 · SVP Finance & Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,430

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 20:58 UTC
Conn MorganChief Finanical Officer
GrantStock Option (right to buy) · Derivative 360,890 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001062993-24-017718 · form4.xml · derivative · entry 2

Conn Morgan · CIK 0001974124 · Chief Finanical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,890

Underlying: Common Stock · 360,890 shares

Expires 2034-10-14

F2 · derivative.exercise_date: The option vests 25% on October 14, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 20:58 UTC
Conn MorganChief Finanical Officer
GrantCommon Stock 60,148 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-017718 · form4.xml · nonDerivative · entry 1

Conn Morgan · CIK 0001974124 · Chief Finanical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,148

F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on October 14, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:04 UTC
Cowan ChadChief Scientific Officer
GrantStock Option (right to buy) · Derivative 446,250 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001062993-24-017405 · form4.xml · derivative · entry 3

Cowan Chad · CIK 0002039294 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,250

Underlying: Common Stock · 446,250 shares

Expires 2034-10-01

F3 · derivative.exercise_date: The option vests 25% on October 1, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:04 UTC
Cowan ChadChief Scientific Officer
GrantCommon Stock 74,376 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-017405 · form4.xml · nonDerivative · entry 1

Cowan Chad · CIK 0002039294 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,806

F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on October 1, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.